Molecular sleuthing: unmasking hidden lymphomas through plasma DNA sequencing.

Area of Science:

• Oncology
• Molecular Diagnostics
• Genetics

Background:

• Diagnosing lymphomas, especially with atypical presentations, is challenging without histological confirmation.
• Conventional diagnostic methods may be inconclusive in certain lymphoma cases.

Purpose of the Study:

• To evaluate the utility of next-generation sequencing of cell-free DNA (cfDNA) for early detection of diffuse large B-cell lymphoma (DLBCL).
• To assess cfDNA's potential as a non-invasive tool for diagnosing occult lymphomas.

Main Methods:

• Analysis of plasma cell-free DNA (cfDNA) using next-generation sequencing.
• Identification of lymphoma-associated mutations in cfDNA samples.
• Comparison of cfDNA findings with subsequent biopsy confirmation.

Main Results:

• cfDNA analysis enabled early detection of DLBCL in two cases, months prior to biopsy confirmation.
• Key lymphoma-associated mutations were identified through cfDNA sequencing, aiding diagnosis.
• cfDNA guided diagnosis when conventional investigations were inconclusive.

Conclusions:

• cfDNA sequencing shows promise as a non-invasive diagnostic tool for detecting lymphomas, particularly in challenging presentations.
• Early detection via cfDNA may facilitate timely intervention and improve patient outcomes for DLBCL.
• Further validation studies are warranted to establish cfDNA's role in routine lymphoma diagnostics.